These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 20413701

  • 1. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
    Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS.
    Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M.
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [Abstract] [Full Text] [Related]

  • 3. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
    Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM.
    Ann Surg; 2009 Sep; 250(3):395-402. PubMed ID: 19661785
    [Abstract] [Full Text] [Related]

  • 4. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
    Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M.
    Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Some new insights in intestinal failure-associated liver disease.
    Goulet O, Joly F, Corriol O, Colomb-Jung V.
    Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
    [Abstract] [Full Text] [Related]

  • 7. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE.
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [Abstract] [Full Text] [Related]

  • 8. Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndrome.
    Tillman EM, Crill CM, Black DD, Hak EB, Lazar LF, Christensen ML, Huang EY, Helms RA.
    Pharmacotherapy; 2011 May; 31(5):503-9. PubMed ID: 21923431
    [Abstract] [Full Text] [Related]

  • 9. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease.
    Sigalet D, Boctor D, Robertson M, Lam V, Brindle M, Sarkhosh K, Driedger L, Sajedi M.
    Eur J Pediatr Surg; 2009 Dec; 19(6):348-53. PubMed ID: 19866409
    [Abstract] [Full Text] [Related]

  • 10. Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome.
    Strang BJ, Reddix BA, Wolk RA.
    Nutr Clin Pract; 2016 Oct; 31(5):647-53. PubMed ID: 27143651
    [Abstract] [Full Text] [Related]

  • 11. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates.
    Nehra D, Fallon EM, Carlson SJ, Potemkin AK, Hevelone ND, Mitchell PD, Gura KM, Puder M.
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):498-505. PubMed ID: 22767698
    [Abstract] [Full Text] [Related]

  • 12. Preventing parenteral nutrition liver disease.
    Kelly DA.
    Early Hum Dev; 2010 Nov; 86(11):683-7. PubMed ID: 20923719
    [Abstract] [Full Text] [Related]

  • 13. Surgical intervention in the setting of parenteral nutrition-associated cholestasis may exacerbate liver injury.
    Arsenault DA, Potemkin AK, Robinson EM, Fallon EM, Ozonoff A, de Meijer VE, Puder M.
    J Pediatr Surg; 2011 Jan; 46(1):122-7. PubMed ID: 21238652
    [Abstract] [Full Text] [Related]

  • 14. The use of Omegaven in treating parenteral nutrition-associated liver disease.
    Park KT, Nespor C, Kerner J.
    J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
    [Abstract] [Full Text] [Related]

  • 15. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants.
    Javid PJ, Collier S, Richardson D, Iglesias J, Gura K, Lo C, Kim HB, Duggan CP, Jaksic T.
    J Pediatr Surg; 2005 Jun; 40(6):1015-8. PubMed ID: 15991188
    [Abstract] [Full Text] [Related]

  • 16. Early enteral fat supplementation with microlipid® and fish oil in the treatment of two premature infants with short bowel.
    Yang Q, Welch CD, Ayers K, Turner C, Pranikoff T.
    Neonatology; 2010 Jun; 98(4):348-53. PubMed ID: 20980771
    [Abstract] [Full Text] [Related]

  • 17. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.
    Koletzko B, Goulet O.
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):321-6. PubMed ID: 20393276
    [Abstract] [Full Text] [Related]

  • 18. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
    Lam HS, Tam YH, Poon TC, Cheung HM, Yu X, Chan BP, Lee KH, Lee BS, Ng PC.
    Neonatology; 2014 May; 105(4):290-6. PubMed ID: 24576844
    [Abstract] [Full Text] [Related]

  • 19. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.
    Burns DL, Gill BM.
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685
    [Abstract] [Full Text] [Related]

  • 20. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
    de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M.
    Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.